Similar Articles
1291 Clinical significance of donor-specific human leukocyte antigen antibodies in liver transplantation
1292 Candidates for liver transplantation with alcoholic liver disease: Psychosocial aspects
1293 Posttransplant lymphoproliferative disorders following liver transplantation: Where are we now?
1294 Active vaccination to prevent de novo hepatitis B virus infection in liver transplantation
1295 Effect of fibulin-5 on adhesion, migration and invasion of hepatocellular carcinoma cells via an integrin-dependent mechanism
1296 Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review
1297 Transoesophageal echocardiography during liver transplantation
1298 Contribution of the toxic advanced glycation end-products-receptor axis in nonalcoholic steatohepatitis-related hepatocellular carcinoma
1299 Role of biomarkers in the prediction and diagnosis of hepatocellular carcinoma
1300 Impact of new treatment options for hepatitis C virus infection in liver transplantation
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA